AWP
GILD icon

Abacus Wealth Partners’s Gilead Sciences GILD Stock Holding History

Abacus Wealth Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$772K Sell
6,107
-6,934
-53% -$914K 0.08% 91
2026
Q1 		$1.82M Buy
13,041
+555
+4% +$77.7K 0.17% 46
2025
Q4 		$1.53M Buy
+12,486
New +$1.52M 0.15% 59
2025
Q3 		– Sell
-1,997
Closed -$221K – 107
2025
Q2 		$221K Buy
+1,997
New +$213K 0.03% 99

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Abacus Wealth Partners's GILD Position: Q2 2026 in Review

Abacus Wealth Partners reduced its Gilead Sciences (GILD) stake by 53% in Q2 2026, selling an estimated $914K and leaving 6,107 shares worth $772K. The position accounts for 0.08% of the portfolio, ranked #91.

Abacus Wealth Partners first reported a position in GILD in Q2 2025 and has held it in 4 quarters since. The position peaked at $1.82M in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Abacus Wealth Partners held 6,107 shares of Gilead Sciences worth $772K as of Q2 2026.
  • Abacus Wealth Partners sold 6,934 Gilead Sciences shares in Q2 2026, an estimated $914K.
  • Gilead Sciences made up 0.08% of Abacus Wealth Partners's portfolio in Q2 2026, its #91 holding.
  • Abacus Wealth Partners first reported a position in Gilead Sciences in Q2 2025 and has held it in 4 quarters since.
  • Abacus Wealth Partners's Gilead Sciences position peaked at $1.82M in Q1 2026.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Abacus Wealth Partners's 13F filing for Q2 2026, filed 22 Jul 2026.